[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2016/21742,2016,A1Locationinpatent:Paragraph0261;0263
[1]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2018/13867,2018,A1Locationinpatent:Paragraph837
[1]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2018/13867,2018,A1
1426290-11-0 | 2-Bromo-4-(trifluoromethoxy)phenylacetylene | AA00HWGD | MFCD23166760
37640-57-6 | Melamine Cyanurate | AA00I7C6 | MFCD00137334
887266-94-6 | 1-Benzoyl-3-[4-bromo-2-(trifluoromethyl)phenyl]thiourea | AA00IFAB | MFCD07368704
1932555-95-7 | (2R,4R)-1-(tert-Butoxycarbonyl)-2-methylpiperidine-4-carboxylic acid | AA00IL9O | MFCD29058646
438029-94-8 | N-(3,4-dichlorophenyl)-1,3-benzothiazol-2-amine | AA019H4X | MFCD03478324
3217-09-2 | 2-Benzylamino-propan-1-ol | AA01AYBB | MFCD00021997
1219274-96-0 | rac Clopidogrel-d4 Hydrogen Sulfate | AA01CB5G | MFCD09840278
104810-47-1 | Poly(oxy-1,2-ethanediyl),a-[3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropyl]-w-[3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]- | AA01DQ4N | MFCD01743055
2113812-63-6 | ethyl 2-(5-cyanopyridin-2-yl)acetate | AA01E963 | MFCD31420672
2108829-86-1 | KU0058948hydrochloride | AA01FPM0